Samsara BioCapital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Samsara BioCapital’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-342,946	Closed	-$20.5M	–	43
2020 Q2	$20.5M	Sell	342,946 -58,100	-14%	-$3.59M	6.6%	4
2020 Q1	$23.8M	Buy	401,046 +94,262	+31%	+$5.5M	13.71%	2
2019 Q4	$16.8M	Sell	306,784 -76,696	-20%	-$2.86M	8.05%	5
2019 Q3	$10.8M	Hold	383,480	–	–	7.37%	6
2019 Q2	$12.7M	Hold	383,480	–	–	8.41%	6
2019 Q1	$13M	Hold	383,480	–	–	10.25%	4
2018 Q4	$10.5M	Buy	+383,480	New	+$9.88M	10.08%	3

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Samsara BioCapital's PRNB Position: Q3 2020 in Review

Samsara BioCapital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 342,946 shares — an estimated $20.5M sold.

Samsara BioCapital first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $23.8M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Samsara BioCapital reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Samsara BioCapital sold 342,946 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $20.5M.
Samsara BioCapital first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Samsara BioCapital's Principia Biopharma Inc. Common Stock position peaked at $23.8M in Q1 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Samsara BioCapital's 13F filing for Q3 2020, filed 16 Nov 2020.